Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06972628 | Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 | recruiting | Phase 2 | 30 | Ebrahim S DelpassandOTHER | 1 | May 15, 2025 | clinicaltrials |
| NCT06459687 | Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer | recruiting | Phase 3 | 440 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | May 14, 2025 | clinicaltrials |
| NCT06971211 |
| Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC(PARTOM) |
| recruiting |
| Phase 2 |
| 40 |
| Jianbin BiOTHER |
| 1 |
| May 14, 2025 |
| clinicaltrials |
| NCT05062707 | Early Ageing During Therapy in AYA Cancer Patients | recruiting | — | 120 | University Medical Center GroningenOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT05795244 | Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) | recruiting | Phase 2 | 30 | Yonsei UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06052033 | Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection | recruiting | N/A | 40 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | May 13, 2025 | clinicaltrials |
| NCT06139575 | Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer | recruiting | Phase 1 / Phase 2 | 90 | Bivision Pharmaceuticals, Inc.INDUSTRY | 1 | May 13, 2025 | clinicaltrials |
| NCT04186585 | Recommended Dose Estimation of BP-C2 | recruiting | Phase 1 | 8 | MeddocOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05938192 | Multimodality Treatments of HPV-related Lesions of the Female Genital Tract | recruiting | — | 200 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 9, 2025 | clinicaltrials |
| NCT05582876 | Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer(PROSPETMR2021) | recruiting | N/A | 366 | Medical University of BialystokOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06216002 | Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery(FIGO) | recruiting | N/A | 622 | Mahidol UniversityOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT06962670 | Predicting Cancer Risk With Digital and Molecular Markers(PräDigt) | recruiting | N/A | 1,250 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT03344835 | Hong Kong Prostate Cancer Study Group Database | recruiting | — | 15,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03893929 | The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population | recruiting | — | 5,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT03914391 | To Identify Potential New Urine Markers for the Screening of Prostate Cancer | recruiting | — | 10,000 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05761093 | Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment | recruiting | — | 306 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06163924 | The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT | recruiting | — | 130 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06262633 | A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer | recruiting | N/A | 103 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06360523 | To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence | recruiting | N/A | 368 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT05647109 | Patient-derived Tumor-like Cell Clusters Predict Progesterone Sensitivity in Patients With Early Endometrial Cancer | recruiting | — | 244 | Peking University People's HospitalOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT04503265 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | recruiting | Phase 1 / Phase 2 | 122 | AtlasMedx, IncorporatedINDUSTRY | 1 | May 1, 2025 | clinicaltrials |
| NCT05836688 | A Biobehavioral Intervention to Reduce Adverse Outcomes in Young Adult Testicular Cancer Survivors | recruiting | N/A | 250 | University of California, IrvineOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT06087783 | PROtein, Leucine and Vitamin D Supplementation In Patients With GYnecologic Cancer Receiving Platinum-based Chemotherapy(PRODIGY-1) | recruiting | N/A | 50 | Fondazione IRCCS Policlinico San Matteo di PaviaOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT05386615 | Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids | recruiting | — | 200 | InSightecINDUSTRY | 2 | Apr 30, 2025 | clinicaltrials |
| NCT05715502 | Focal Salvage Brachytherapy Study (FocaSaBra)(FocaSaBra) | recruiting | N/A | 100 | The Greater Poland Cancer CentreOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06946771 | Exploring the Correlation Between MRI Image Characteristics and Diagnosis, Pathology and Prognosis in Patients With Prostate Lesions | recruiting | — | 500 | Zhen LiOTHER | 1 | Apr 27, 2025 | clinicaltrials |
| NCT05407987 | Ferric Derisomaltose and Outcomes in the Recovery of Gynecologic Oncology: ERAS (Enhanced Recovery After Surgery)(FORGE II) | recruiting | Phase 3 | 82 | AHS Cancer Control AlbertaOTHER | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06945315 | SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) | recruiting | Phase 3 | 196 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 25, 2025 | clinicaltrials |
| NCT06942416 | Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer | recruiting | Phase 2 | 36 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT06306170 | Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)(GYN-ART) | recruiting | — | 1,000 | IRCCS San RaffaeleOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT06415318 | TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer | recruiting | Phase 2 | 25 | Sun Yat-sen UniversityOTHER | 1 | Apr 22, 2025 | clinicaltrials |
| NCT05947513 | Concomitant Curcumin Palliative Radiotherapy in Advanced Cervical Cancer Trial(CuPRAC) | recruiting | N/A | 27 | Addis Ababa UniversityOTHER | 1 | Apr 20, 2025 | clinicaltrials |
| NCT06702995 | Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 / Phase 2 | 307 | Evopoint Biosciences Inc.INDUSTRY | 1 | Apr 20, 2025 | clinicaltrials |
| NCT05738252 | Frailty Assessments for Risk Assessment in Gynecologic Oncology Patients(FARGO) | recruiting | — | 280 | Population Health Research InstituteOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06686030 | Combination Therapy of AK112 With Chemotherapy and/or Olaparib in Platinum-sensitive Ovarian Cancer | recruiting | Phase 2 | 150 | AkesoINDUSTRY | 1 | Apr 16, 2025 | clinicaltrials |
| NCT06926374 | Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery | recruiting | N/A | 90 | Chinese University of Hong KongOTHER | 1 | Apr 16, 2025 | clinicaltrials |
| NCT05857631 | Postoperative Hypofractionated Radiation in Cervical and Endometrial Tumours: Phase II Study(PARCERII) | recruiting | N/A | 90 | Tata Memorial CentreOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT04705467 | 3DUS Imaging of Needles in Gynecological Brachytherapy | recruiting | N/A | 35 | Western University, CanadaOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06480110 | Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer | recruiting | Phase 1 / Phase 2 | 30 | Rigshospitalet, DenmarkOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT06705075 | Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE | recruiting | Phase 2 | 80 | Thomas Jefferson UniversityOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT03903835 | ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer(ProBio) | recruiting | Phase 3 | 750 | Karolinska InstitutetOTHER | 4 | Apr 9, 2025 | clinicaltrials |
| NCT05421650 | Therapeutic Effect of Surgical Debulking of Metastatic Lymph Nodes in Cervical Cancer Stage IIICr | recruiting | N/A | 240 | CHA UniversityOTHER | 5 | Apr 9, 2025 | clinicaltrials |
| NCT06920342 | Attitudes to Gynae Oncology Care Location - GRACEFUL(GRACEFUL) | recruiting | — | 600 | Somerset NHS Foundation TrustOTHER | 1 | Apr 9, 2025 | clinicaltrials |
| NCT06917092 | QL1706-Based Therapy Post-PD-1/L1 Failure in Advanced Endometrial Cancer(QLPPEC/GOG-003) | recruiting | Phase 2 | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT06740071 | The Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy | recruiting | N/A | 100 | The University of Hong KongOTHER | 2 | Apr 4, 2025 | clinicaltrials |
| NCT06482489 | Accurate Prostate Cancer Following Using Low-Field MRI (Low-PRISM)(Low-PRISM) | recruiting | — | 74 | University of Lausanne HospitalsOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06907771 | Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer(PACO) | recruiting | — | 130 | University Hospital, Strasbourg, FranceOTHER | 1 | Apr 2, 2025 | clinicaltrials |
| NCT05179447 | PROfiling Based Endometrial Cancer Adjuvant Therapy(PROBEAT) | recruiting | N/A | 590 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT05284877 | The Organ Transplant Recipient HPV and Skin Cancer Study | recruiting | — | 1,500 | Merete HaedersdalOTHER | 1 | Apr 1, 2025 | clinicaltrials |
Data updated 24 days agoSource updated May 15, 2025source: clinicaltrials